Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway
- PMID: 21812107
- DOI: 10.1002/mnfr.201100147
Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway
Abstract
Scope: The lectin-like oxidized low-density lipoprotein receptor (LOX-1) is one pivot receptor for oxidized low-density lipoprotein (oxLDL) in human endothelial cells. Co-enzyme Q10 (Co Q10) has been widely used in clinical intervention. However, the molecular mechanisms underlying its protective effects against oxidative stress in endothelial cells are still largely unknown. This study was designed to test the hypothesis that Co Q10 mitigates oxLDL-induced endothelial oxidative injuries via modulation of LOX-1-mediated reactive oxygen species (ROS) generation and explored the role of AMP-activated protein kinase (AMPK), a negative regulator of NADPH oxidase.
Methods and results: Human umbilical vein endothelial cells (HUVECs) were pretreated with Co Q10 and then incubated with oxLDL for 24 h. Co Q10 attenuated oxLDL-elicited LOX-1 expression and ROS generation by suppression of NADPH oxidase activation. Co Q10 rescued dephosphorylation of AMPK caused by oxLDL that in turn led to an activation of NADPH oxidase by PKC. The results were confirmed using AMPK siRNA. Moreover, oxLDL-suppressed Akt/eNOS and enhanced p38 phosphorylation, which in turn activated NF-κB pathway. These detrimental events were ameliorated by Co Q10.
Conclusion: These results provide new highlight onto the possible molecular mechanisms of how Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Roles of LOX-1 in microvascular dysfunction.Microvasc Res. 2016 May;105:132-40. doi: 10.1016/j.mvr.2016.02.006. Epub 2016 Feb 18. Microvasc Res. 2016. PMID: 26907636 Review.
-
Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation.Mol Nutr Food Res. 2015 Oct;59(10):1905-17. doi: 10.1002/mnfr.201500144. Epub 2015 Aug 26. Mol Nutr Food Res. 2015. PMID: 26202455
-
LOX-1 and ROS, inseparable factors in the process of endothelial damage.Free Radic Res. 2014 Aug;48(8):841-8. doi: 10.3109/10715762.2014.929122. Epub 2014 Jun 23. Free Radic Res. 2014. PMID: 24886290 Review.
-
Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS.Can J Physiol Pharmacol. 2014 Apr;92(4):299-306. doi: 10.1139/cjpp-2013-0322. Epub 2014 Jan 10. Can J Physiol Pharmacol. 2014. PMID: 24708212
-
Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.J Vasc Surg. 2010 Nov;52(5):1290-300. doi: 10.1016/j.jvs.2010.04.085. Epub 2010 Aug 8. J Vasc Surg. 2010. PMID: 20692795
Cited by
-
Prospects of Intravenous Coenzyme Q10 Administration in Emergency Ischemic Conditions.Life (Basel). 2024 Jan 17;14(1):134. doi: 10.3390/life14010134. Life (Basel). 2024. PMID: 38255749 Free PMC article. Review.
-
Ubiquinol attenuates γ-radiation induced coronary and aortic changes via PDGF/p38 MAPK/ICAM-1 related pathway.Sci Rep. 2023 Dec 27;13(1):22959. doi: 10.1038/s41598-023-50218-w. Sci Rep. 2023. PMID: 38151557 Free PMC article.
-
Coenzyme Q10 Protects Against Hyperlipidemia-Induced Osteoporosis by Improving Mitochondrial Function via Modulating miR-130b-3p/PGC-1α Pathway.Calcif Tissue Int. 2024 Feb;114(2):182-199. doi: 10.1007/s00223-023-01161-5. Epub 2023 Dec 6. Calcif Tissue Int. 2024. PMID: 38055044
-
LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects.Int J Mol Sci. 2023 Mar 7;24(6):5082. doi: 10.3390/ijms24065082. Int J Mol Sci. 2023. PMID: 36982155 Free PMC article.
-
Royal jelly plus coenzyme Q10 supplementation improves high-intensity interval exercise performance via changes in plasmatic and salivary biomarkers of oxidative stress and muscle damage in swimmers: a randomized, double-blind, placebo-controlled pilot trial.J Int Soc Sports Nutr. 2022 Jun 16;19(1):239-257. doi: 10.1080/15502783.2022.2086015. eCollection 2022. J Int Soc Sports Nutr. 2022. PMID: 35813842 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources